Neuromuscular
quality measures
Find measures to improve care for patients diagnosed with a neuromuscular disorder.
Amyotrophic Lateral Sclerosis (ALS) (2023)
Measure Specifications
- ALS Support Services
- Disease-Modifying Pharmacotherapy Discussion with Patients with ALS
- Screening for Malnutrition and Dysphagia and Appropriate Referral for Patients with ALS
- Screening for Respiratory Impairment and Appropriate Intervention for Patients with ALS
- ALS Multidisciplinary Care Plan Developed or Updated
- ALS Patient Care Preferences
Muscular Dystrophy (2013)
Reaffirmed October 27, 2017
Measure Specifications
- Patients with DMD prescribed appropriate disease modifying pharmaceutical therapy
- MD multidisciplinary care plan developed or updated
- Evaluation of pulmonary status ordered
- Evaluation of cardiac status ordered
- Scoliosis evaluation ordered
- Patient referred for physical, occupational, or speech/swallowing therapy
- Nutrition status or growth trajectories monitored
- Patient queried about pain and pain interference with function
- Patient counseled about advanced health care decision making palliative care, or end of life issues
Inpatient and Emergency (2015)
Measure Specifications
- Reduction of urinary catheters for patients with neurological conditions
- Delirium risk factor screening and preventative protocol
- Non-pharmacological treatment of delirium
- Immunosuppressive treatment for GBS
- Immunosuppressive therapy for myasthenic crisis
- Discussion and documentation of advanced directives
- Discussion and documentation of goals of care
Measures Under Development
Inpatient & Emergency - Work group forming 2022
General Neurology - Work group forming 2022
Child Neurology - Update in process with public comment planned 2022
Stroke - Update in process with public comment planned 2022
Related Content
Neuromuscular Guidelines